ABOUT US
LOGIN STATUS
SEARCH

Medical Staff

CHANGGAO YANG

M.D., PhD, F.C.A.P., FRCPC

Dr. Yang is the founder and medical director of Sterling Pathology National Laboratories. He received his Gastrointestinal Pathology training in Canada with Dr. Paul Manley and Dr. David Hurlbut. Dr. Manley received his training at Stanford University with a life-long dedication to Gastrointestinal Pathology and Dr. Hurlbut received his training in Boston at Harvard Deaconess Medical Center. Dr. Yang furthered his medical education with a fellowship in Surgical Pathology at UCLA, and in Gastrointestinal Pathology with Dr. Klaus Lewin, a world-renowned Gastrointestinal Pathologist.

ELLIE LEKOV

M.D., F.C.A.P.

Dr. Lekov provides expertise in Gastrointestinal Pathology, Uropathology, and Dermatopathology at Sterling Pathology National Laboratories. Dr. Lekov graduated the Residency Program-AP/CP at Harbor-UCLA in 2009. She served as chief resident and was responsible for frozen section diagnosis and teaching the junior residents. She worked on several research projects resulting in papers discussing an unusual case of Lymphangioma of the Small Bowel. After finishing the residency program, she continued as the Surgical Pathology Fellow at Harbor-UCLA with a focus on Dermatopathology, which she completed in 2010.

HUA LI

Ph.D., DABCC, CGMBS

Director and supervisor of Research and Development of Clinical Laboratory Technology at Sterling Pathology National Laboratories, Dr. Hua Li received his Ph.D. from China Agricultural University in Beijing, China. After his postdoctoral fellowship at the School of Life Sciences at Tsinghua University in Beijing, Dr. Li moved to the United States and continued his postdoctoral work as a researcher within the Department of Medicine at Northwestern University in Chicago, IL. Dr. Li’s research has contributed to the development of Next Generation Sequencing (NGS) based LDT assays in the field of molecular oncology and genetics.

ANOOSHEH EBAEE

M.D., F.C.A.P.

Dr. Ebaee is a board-certified, experienced hematopathologist and board-certified AP/CP Pathologist with a passion for research and leadership. She has expertise in diagnosing and interpreting hematologic and gastrointestinal diseases, honed through her roles as Supervisor & Co-Director at Sterling Pathology National Lab. Dr. Ebaee served as Chief Resident at Harbor UCLA. She graduated from Harbor UCLA, AP/CP pathology residency and consequently completed her hematopathology fellowship at UCLA in 2019. She is board-certified in AP/CP and hematopathology.

PAUL KIRSHMAN

M.D.

Dr. Paul Kirshman is a nationally recognized Uropathologist who provides clinical and anatomical Uropathology Consultation with a focus on prostate and bladder pathology. Dr. Kirshman has over two decades of experience and interest in prostate cancer and bladder cancer. He received his MD from the University of Montpellier, France and received his residency training at Westchester County Medical Center, Valhalla, New York. He then received fellowship training in Molecular Pathology under Dr. Mark Sobel at the National Institute of Health (NIH) in Bethesda, Maryland.

PAUL SHITABATA

M.D.

Dr. Shitabata is board certified in Dermatopathology, Clinical and Anatomical Pathology. Dr. Shitabata has been practicing Dermatopathology since 1994. He currently serves as the Director of Dermatopathology for the Dermatology Residency Program for the Harbor-UCLA Medical Center. He is a Clinical Associate Professor of Medicine and Pathology at UCLA-David Geffen School of Medicine, a Clinical Professor of Pathology at the Western University of Health Sciences College of Osteopathic Medicine, and an Adjunct Professor of Pathology and Dermatology at Touro University School of Osteopathic Medicine. Dr. Shitabata is also the President and Medical Director of the Dermatopathology Institute.